Stock Research for ALIM

ALIM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALIM Stock Chart & Research Data

The ALIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALIM Due diligence Resources & Stock Charts

The ALIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALIM Detailed Price Forecast - CNN Money CNN View ALIM Detailed Summary - Google Finance
Yahoo View ALIM Detailed Summary - Yahoo! Finance Zacks View ALIM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALIM Trends & Analysis - Trade-Ideas Barrons View ALIM Major Holders - Barrons
NASDAQ View ALIM Call Transcripts - NASDAQ Seeking View ALIM Breaking News & Analysis - Seeking Alpha
Spotlight View ALIM Annual Report - CompanySpotlight.com OTC Report View ALIM OTC Short Report - OTCShortReport.com
TradeKing View ALIM Fundamentals - TradeKing Charts View ALIM SEC Filings - Bar Chart
WSJ View Historical Prices for ALIM - The WSJ Morningstar View Performance/Total Return for ALIM - Morningstar
MarketWatch View the Analyst Estimates for ALIM - MarketWatch CNBC View the Earnings History for ALIM - CNBC
StockMarketWatch View the ALIM Earnings - StockMarketWatch MacroAxis View ALIM Buy or Sell Recommendations - MacroAxis
Bullish View the ALIM Bullish Patterns - American Bulls Short Pains View ALIM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALIM Stock Mentions - StockTwits PennyStocks View ALIM Stock Mentions - PennyStockTweets
Twitter View ALIM Stock Mentions - Twitter Invest Hub View ALIM Investment Forum News - Investor Hub
Yahoo View ALIM Stock Mentions - Yahoo! Message Board Seeking Alpha View ALIM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALIM - SECform4.com Insider Cow View Insider Transactions for ALIM - Insider Cow
CNBC View ALIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALIM - OTC Markets
Yahoo View Insider Transactions for ALIM - Yahoo! Finance NASDAQ View Institutional Holdings for ALIM - NASDAQ


Stock Charts

FinViz View ALIM Stock Insight & Charts - FinViz.com StockCharts View ALIM Investment Charts - StockCharts.com
BarChart View ALIM Stock Overview & Charts - BarChart Trading View View ALIM User Generated Charts - Trading View




Latest Financial News for ALIM


How Much Of Alimera Sciences, Inc. (NASDAQ:ALIM) Do Institutions Own?
Posted on Tuesday August 06, 2019

Every investor in Alimera Sciences, Inc. (NASDAQ:ALIM) should be aware of the most powerful shareholder groups...


Alimera Announces ILUVIEN® Regulatory Approval in Australia for the Treatment of Diabetic Macular Edema
Posted on Monday August 05, 2019

Alimera Sciences, Inc. (ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces today that the Australian Therapeutic Goods Administration (TGA), the division of the Australian Department of Health that oversees the availability of medical products, has approved ILUVIEN® (190 micrograms intravitreal implant in applicator) for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.


Edited Transcript of ALIM earnings conference call or presentation 30-Jul-19 1:00pm GMT
Posted on Saturday August 03, 2019

Q2 2019 Alimera Sciences Inc Earnings Call


Alimera Sciences Announces Second Quarter 2019 Financial Results and Provides Corporate Update
Posted on Monday July 29, 2019

Second Quarter and Recent Company Highlights: Consolidated Net Revenue Up 2% Compared to Second Quarter 2018International Net Revenue Up 21% Compared to Second Quarter.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.